Drug-induced Gingival Overgrowth Related to Sirolimus and Felodipine |
Park, Youn-Jung
(Department of Orofacial Pain and Oral Medicine, Dental Hospital, Yonsei University College of Dentisty)
Lee, Joo-Hee (Department of Orofacial Pain and Oral Medicine, Dental Hospital, Yonsei University College of Dentisty) Kim, Young-Gun (Department of Orofacial Pain and Oral Medicine, Dental Hospital, Yonsei University College of Dentisty) Kwon, Jeong-Seung (Department of Orofacial Pain and Oral Medicine, Dental Hospital, Yonsei University College of Dentisty) Ahn, Hyung-Joon (Department of Orofacial Pain and Oral Medicine, Dental Hospital, Yonsei University College of Dentisty) Choi, Jong-Hoon (Department of Orofacial Pain and Oral Medicine, Dental Hospital, Yonsei University College of Dentisty) |
1 | Brown RS, Arany PR. Mechanism of drug-induced gingival overgrowth revisited: a unifying hypothesis. Oral Dis 2015;21:e51-e61. DOI |
2 | Dongari-Bagtzoglou A; Research, Science and Therapy Committee, American Academy of Periodontology. Drug-associated gingival enlargement. J Periodontol 2004;75:1424-1431. DOI |
3 | Livada R, Shiloah J. Calcium channel blocker-induced gingival enlargement. J Hum Hypertens 2014;28:10-14. DOI |
4 | Cota LO, Aquino DR, Franco GC, Cortelli JR, Cortelli SC, Costa FO. Gingival overgrowth in subjects under immunosuppressive regimens based on cyclosporine, tacrolimus, or sirolimus. J Clin Periodontol 2010;37:894-902. DOI |
5 | Perez-Barrio S, Gonzalez Hermosa MR, Diaz-Perez JL. Gingival hyperplasia secondary to everolimus therapy. Actas Dermosifil-iogr 2010;101:372-373. DOI |
6 | Ellis JS, Seymour RA, Steele JG, Robertson P, Butler TJ, Thomason JM. Prevalence of gingival overgrowth induced by calcium channel blockers: a community-based study. J Periodontol 1999;70:63-67. DOI |
7 | Magee CC, Pascual M. Update in renal transplantation. Arch Intern Med 2004;164:1373-1388. DOI |
8 | Danovitch GM. Immunosuppressant-induced metabolic toxicities. Transplant Rev 2000;14:65-81. DOI |
9 | Tyldesley WR, Rotter E. Gingival hyperplasia induced by cyclosporin-A. Br Dent J 1984;157:305-309. DOI |
10 | Cota LO, Oliveira AP, Costa JE, Cortelli SC, Costa FO. Gingival status of Brazilian renal transplant recipients under sirolimusbased regimens. J Periodontol 2008;79:2060-2068. DOI |
11 | Lima RB, Benini V, Sens YA. Gingival overgrowth in renal transplant recipients: a study concerning prevalence, severity, periodontal, and predisposing factors. Transplant Proc 2008;40:1425-1428. DOI |
12 | Camargo PM, Melnick PR, Pirih FQ, Lagos R, Takei HH. Treatment of drug-induced gingival enlargement: aesthetic and functional considerations. Periodontol 2000 2001;27:131-138. DOI |
13 | Pilatti GL, Sampaio JE. The influence of chlorhexidine on the severity of cyclosporin A-induced gingival overgrowth. J Periodontol 1997;68:900-904. DOI |
14 | Arya R, Gulati S, Kabra M, Sahu JK, Kalra V. Folic acid supplementation prevents phenytoin-induced gingival overgrowth in children. Neurology 2011;76:1338-1343. DOI |
15 | Watson CJE. Sirolimus (rapamycin) in clinical transplantation. Transplant Rev 2001;15:165-177. DOI |
![]() |